Department of Surgery, Mount Sinai Hospital, and University of Toronto, Toronto, ON, Canada.
Ann Surg Oncol. 2012 Jul;19(7):2212-23. doi: 10.1245/s10434-011-2210-5. Epub 2012 Jan 20.
Magnetic resonance imaging (MRI) is increasingly being used for rectal cancer staging. The purpose of this study was to determine the accuracy of phased array MRI for T category (T1-2 vs. T3-4), lymph node metastases, and circumferential resection margin (CRM) involvement in primary rectal cancer.
Medline, Embase, and Cochrane databases were searched using combinations of keywords relating to rectal cancer and MRI. Reference lists of included articles were also searched by hand. Inclusion criteria were: (1) original article published January 2000-March 2011, (2) use of phased array coil MRI, (3) histopathology used as reference standard, and (4) raw data available to create 2×2 contingency tables. Patients who underwent preoperative long-course radiotherapy or chemoradiotherapy were excluded. Two reviewers independently extracted data. Sensitivity, specificity, and diagnostic odds ratio were estimated for each outcome using hierarchical summary receiver-operating characteristics and bivariate random effects modeling.
Twenty-one studies were included in the analysis. There was notable heterogeneity among studies. MRI specificity was significantly higher for CRM involvement [94%, 95% confidence interval (CI) 88-97] than for T category (75%, 95% CI 68-80) and lymph nodes (71%, 95% CI 59-81). There was no significant difference in sensitivity between the three elements as a result of wide overlapping CIs. Diagnostic odds ratio was significantly higher for CRM (56.1, 95% CI 15.3-205.8) than for lymph nodes (8.3, 95% CI 4.6-14.7) but did not differ significantly from T category (20.4, 95% CI 11.1-37.3).
MRI has good accuracy for both CRM and T category and should be considered for preoperative rectal cancer staging. In contrast, lymph node assessment is poor on MRI.
磁共振成像(MRI)越来越多地用于直肠癌分期。本研究旨在确定相控阵 MRI 对 T 分期(T1-2 与 T3-4)、淋巴结转移和原发性直肠癌的环周切缘(CRM)受累的准确性。
使用与直肠癌和 MRI 相关的关键词组合,在 Medline、Embase 和 Cochrane 数据库中进行搜索。还通过手工搜索纳入文章的参考文献列表。纳入标准为:(1)2000 年 1 月至 2011 年 3 月发表的原始文章,(2)使用相控阵线圈 MRI,(3)以组织病理学作为参考标准,(4)有可用的原始数据来创建 2×2 四格表。排除接受术前长程放疗或放化疗的患者。两名审查员独立提取数据。使用层次汇总受试者工作特征和双变量随机效应模型为每个结局估计敏感性、特异性和诊断优势比。
21 项研究纳入分析。研究之间存在显著的异质性。MRI 对 CRM 受累的特异性显著高于 T 分期(75%,95%置信区间[CI]为 88-97)和淋巴结(71%,95% CI 为 59-81)。由于 CI 广泛重叠,三种元素的敏感性没有显著差异。诊断优势比 CRM(56.1,95%CI 为 15.3-205.8)显著高于淋巴结(8.3,95%CI 为 4.6-14.7),但与 T 分期(20.4,95%CI 为 11.1-37.3)无显著差异。
MRI 对 CRM 和 T 分期均具有良好的准确性,应考虑用于术前直肠癌分期。相比之下,MRI 对淋巴结的评估效果较差。